Youbiao He

Youbiao He, Forrest Sheng Bao

Circuit routing is a fundamental problem in designing electronic systems such as integrated circuits (ICs) and printed circuit boards (PCBs) which form the hardware of electronics and computers. Like finding paths between pairs of locations, circuit routing generates traces of wires to connect contacts or leads of circuit components. It is challenging because finding paths between dense and massive electronic components involves a very large search space. Existing solutions are either manually designed with domain knowledge or tailored to specific design rules, hence, difficult to adapt to new problems or design needs. Therefore, a general routing approach is highly desired. In this paper, we model the circuit routing as a sequential decision-making problem, and solve it by Monte Carlo tree search (MCTS) with deep neural network (DNN) guided rollout. It could be easily extended to routing cases with more routing constraints and optimization goals. Experiments on randomly generated single-layer circuits show the potential to route complex circuits. The proposed approach can solve the problems that benchmark methods such as sequential A* method and Lee's algorithm cannot solve, and can also outperform the vanilla MCTS approach.

Forrest Sheng Bao, Youbiao He, Jie Liu et al.

The COVID-19 is sweeping the world with deadly consequences. Its contagious nature and clinical similarity to other pneumonias make separating subjects contracted with COVID-19 and non-COVID-19 viral pneumonia a priority and a challenge. However, COVID-19 testing has been greatly limited by the availability and cost of existing methods, even in developed countries like the US. Intrigued by the wide availability of routine blood tests, we propose to leverage them for COVID-19 testing using the power of machine learning. Two proven-robust machine learning model families, random forests (RFs) and support vector machines (SVMs), are employed to tackle the challenge. Trained on blood data from 208 moderate COVID-19 subjects and 86 subjects with non-COVID-19 moderate viral pneumonia, the best result is obtained in an SVM-based classifier with an accuracy of 84%, a sensitivity of 88%, a specificity of 80%, and a precision of 92%. The results are found explainable from both machine learning and medical perspectives. A privacy-protected web portal is set up to help medical personnel in their practice and the trained models are released for developers to further build other applications. We hope our results can help the world fight this pandemic and welcome clinical verification of our approach on larger populations.